Trending NewsTrending NewsLowest-Rated StocksLowest-RatedNASDAQ:FTRE Fortrea (FTRE) Stock Price, News & Analysis $5.46 -0.28 (-4.88%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$6.05 +0.59 (+10.81%) As of 08/1/2025 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Fortrea Stock (NASDAQ:FTRE) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Fortrea alerts:Sign Up Key Stats Today's Range$5.27▼$6.0450-Day Range$4.06▼$6.8752-Week Range$3.97▼$27.26Volume1.56 million shsAverage Volume1.82 million shsMarket Capitalization$494.13 millionP/E RatioN/ADividend YieldN/APrice Target$14.00Consensus RatingReduce Company Overview Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. The company operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process. The company offers delivery models that include full service, functional service provider, and hybrid service structures. It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services, as well as consulting services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina. Read More Fortrea Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks82nd Percentile Overall ScoreFTRE MarketRank™: Fortrea scored higher than 82% of companies evaluated by MarketBeat, and ranked 166th out of 919 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.9 / 5Analyst RatingReduce Consensus RatingFortrea has received a consensus rating of Reduce. The company's average rating score is 1.86, and is based on no buy ratings, 12 hold ratings, and 2 sell ratings.Amount of Analyst CoverageFortrea has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Fortrea's stock forecast and price target. Earnings and Valuation3.8 / 5Proj. Earnings Growth150.98% Earnings GrowthEarnings for Fortrea are expected to grow by 150.98% in the coming year, from $0.51 to $1.28 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Fortrea is -0.62, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Fortrea is -0.62, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioFortrea has a PEG Ratio of 0.39. PEG Ratios below 1 indicate that a company could be undervalued.Price to Book Value per Share RatioFortrea has a P/B Ratio of 0.36. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Fortrea's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted15.90% of the float of Fortrea has been sold short.Short Interest Ratio / Days to CoverFortrea has a short interest ratio ("days to cover") of 5.Change versus previous monthShort interest in Fortrea has recently decreased by 6.40%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldFortrea does not currently pay a dividend.Dividend GrowthFortrea does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted15.90% of the float of Fortrea has been sold short.Short Interest Ratio / Days to CoverFortrea has a short interest ratio ("days to cover") of 5.Change versus previous monthShort interest in Fortrea has recently decreased by 6.40%, indicating that investor sentiment is improving significantly. News and Social Media2.3 / 5News Sentiment0.16 News SentimentFortrea has a news sentiment score of 0.16. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.45 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 39 news articles for Fortrea this week, compared to 12 articles on an average week.Search Interest6 people have searched for FTRE on MarketBeat in the last 30 days. This is an increase of 50% compared to the previous 30 days. Company Ownership0.8 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Fortrea insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $22,189.00 in company stock.Percentage Held by InsidersOnly 0.38% of the stock of Fortrea is held by insiders.Read more about Fortrea's insider trading history. Receive FTRE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Fortrea and its competitors with MarketBeat's FREE daily newsletter. Email Address FTRE Stock News HeadlinesFINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Fortrea HoldingsAugust 1 at 1:44 PM | tmcnet.comPomerantz Law Firm Announces the Filing of a Class Action Against Fortrea Holdings, Inc. and Certain Officers – FTREAugust 1 at 10:00 AM | globenewswire.comOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce competitors, dethroning the AI Chip King. But there's a critical component that AI data centers need just as badly as chips. The demand is so massive that a single data center uses enough of it to stretch around the earth eight times. While the media hypes up AI chips, the smart money has found the next big thing. Discover Futurist Eric Fry's "Nvidia-killer" stock ideas.August 2 at 2:00 AM | InvestorPlace (Ad)Investors who lost money on Fortrea Holdings Inc.(FTRE) should contact Levi & Korsinsky about pending Class Action - FTREAugust 1 at 9:00 AM | prnewswire.comFORTREA FINAL DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors in Fortrea Holdings (FTRE) of The August 1st Deadline and Urges Investors to Contact The FirmAugust 1 at 8:02 AM | globenewswire.comLevi & Korsinsky Notifies Shareholders of Fortrea Holdings Inc. (FTRE) of a Class Action Lawsuit and an Upcoming DeadlineJuly 31 at 5:40 PM | theglobeandmail.comFTRE DEADLINE TOMORROW: ROSEN, LEADING INVESTOR COUNSEL, Encourages Fortrea Holdings, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 1 Deadline in Securities Class Action – FTREJuly 31 at 5:07 PM | globenewswire.comFortrea Holdings Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – FTREJuly 31 at 4:06 PM | globenewswire.comSee More Headlines FTRE Stock Analysis - Frequently Asked Questions How have FTRE shares performed this year? Fortrea's stock was trading at $18.65 on January 1st, 2025. Since then, FTRE shares have decreased by 70.7% and is now trading at $5.46. How were Fortrea's earnings last quarter? Fortrea Holdings Inc. (NASDAQ:FTRE) announced its quarterly earnings data on Monday, May, 12th. The company reported $0.02 earnings per share for the quarter, beating analysts' consensus estimates of ($0.07) by $0.09. The firm earned $651.30 million during the quarter, compared to analysts' expectations of $609.63 million. Fortrea had a negative net margin of 29.43% and a positive trailing twelve-month return on equity of 2.84%. Read the conference call transcript. Who are Fortrea's major shareholders? Top institutional investors of Fortrea include Assenagon Asset Management S.A. (0.41%), Allianz Asset Management GmbH (0.28%), Sequoia Financial Advisors LLC (0.19%) and CWM LLC (0.14%). Insiders that own company stock include Thomas Pike, Jill G Mcconnell, Peter M Neupert and James S Hanson. View institutional ownership trends. How do I buy shares of Fortrea? Shares of FTRE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Fortrea own? Based on aggregate information from My MarketBeat watchlists, some other companies that Fortrea investors own include AU Optronics (AUOTY), Waste Connections (WCN), American Water Works (AWK), The RMR Group (RMR), DiamondRock Hospitality (DRH), iShares Micro-Cap ETF (IWC) and Triple Flag Precious Metals (TFPM). Company Calendar Last Earnings5/12/2025Today8/02/2025Next Earnings (Estimated)8/06/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED - BIOMED/GENE Sub-IndustryHealthcare Current SymbolNASDAQ:FTRE CIK1965040 Webwww.fortrea.com Phone877-495-0816FaxN/AEmployees15,500Year FoundedN/APrice Target and Rating Average Price Target for Fortrea$14.00 High Price Target$25.00 Low Price Target$5.00 Potential Upside/Downside+156.4%Consensus RatingReduce Rating Score (0-4)1.86 Research Coverage14 Analysts Profitability EPS (Trailing Twelve Months)($8.79) Trailing P/E RatioN/A Forward P/E Ratio10.71 P/E Growth0.39Net Income-$328.50 million Net Margins-29.43% Pretax Margin-27.83% Return on Equity2.84% Return on Assets1.06% Debt Debt-to-Equity Ratio1.22 Current Ratio0.97 Quick Ratio0.97 Sales & Book Value Annual Sales$2.70 billion Price / Sales0.18 Cash Flow$1.50 per share Price / Cash Flow3.65 Book Value$15.19 per share Price / Book0.36Miscellaneous Outstanding Shares90,500,000Free Float90,156,000Market Cap$494.13 million OptionableOptionable Beta1.80 Social Links A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free Report This page (NASDAQ:FTRE) was last updated on 8/2/2025 by MarketBeat.com Staff From Our Partners379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | SponsoredTrump’s crypto advisor may have revealed the next big crypto opportunityWhile investors chase Bitcoin toward $100K, D.C. insiders are quietly loading up on something else. One of Tru...Weiss Ratings | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredToo busy to trade? Good.Too busy to trade? That might be your edge. This after-hours strategy is built for people who don’t sit at ...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredDon’t Touch Tesla Stock Without Reading This FirstJeff Brown says he wouldn’t touch Tesla stock right now—and the reason might shock you. A 40-year Wall Stre...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fortrea Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Fortrea With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.